{"id":"https://openalex.org/W2166050005","doi":"https://doi.org/10.1345/aph.1k205","title":"Comparing Adherence to and Persistence with Antipsychotic Therapy Among Patients with Bipolar Disorder","display_name":"Comparing Adherence to and Persistence with Antipsychotic Therapy Among Patients with Bipolar Disorder","publication_year":2007,"publication_date":"2007-09-25","ids":{"openalex":"https://openalex.org/W2166050005","doi":"https://doi.org/10.1345/aph.1k205","mag":"2166050005","pmid":"https://pubmed.ncbi.nlm.nih.gov/17925501"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1k205","doi":"https://doi.org/10.1345/aph.1k205","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1k205","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078653615","display_name":"Mariam Hassan","orcid":"https://orcid.org/0009-0008-4798-3602","observed_orcids":["https://orcid.org/0009-0008-4798-3602"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Hassan","raw_affiliation_strings":["Health and Outcomes Research, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA. Mariam.Hassan@astrazeneca.com","Health and Outcomes Research, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health and Outcomes Research, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA. Mariam.Hassan@astrazeneca.com","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Health and Outcomes Research, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109236139","display_name":"S. Suresh Madhavan","orcid":"https://orcid.org/0000-0001-6746-5011","observed_orcids":["https://orcid.org/0000-0001-6746-5011"]},"institutions":[{"id":"https://openalex.org/I12097938","display_name":"West Virginia University","ror":"https://ror.org/011vxgd24","country_code":"US","type":"education","lineage":["https://openalex.org/I12097938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S S. Madhavan","raw_affiliation_strings":["S Suresh Madhavan PhD, Professor and Chair, Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North), Morgantown, WV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S Suresh Madhavan PhD, Professor and Chair, Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North), Morgantown, WV","institution_ids":["https://openalex.org/I12097938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018579603","display_name":"Iftekhar D. Kalsekar","orcid":"https://orcid.org/0000-0001-5232-5972","observed_orcids":["https://orcid.org/0000-0001-5232-5972"]},"institutions":[{"id":"https://openalex.org/I110678235","display_name":"Butler University","ror":"https://ror.org/05gq3a412","country_code":"US","type":"education","lineage":["https://openalex.org/I110678235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. D Kalsekar","raw_affiliation_strings":["Iftekhar D Kalsekar PhD, Assistant Professor of Pharmacy Practice, College of Pharmacy and Health Science, Butler University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Iftekhar D Kalsekar PhD, Assistant Professor of Pharmacy Practice, College of Pharmacy and Health Science, Butler University, Indianapolis, IN","institution_ids":["https://openalex.org/I110678235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108520348","display_name":"Eugene H. Makela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12097938","display_name":"West Virginia University","ror":"https://ror.org/011vxgd24","country_code":"US","type":"education","lineage":["https://openalex.org/I12097938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. H Makela","raw_affiliation_strings":["Eugene H Makela PharmD, Associate Professor, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eugene H Makela PharmD, Associate Professor, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)","institution_ids":["https://openalex.org/I12097938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017241608","display_name":"Kitty Rajagopalan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Rajagopalan","raw_affiliation_strings":["Kitty Rajagopalan PhD, Director, Global Health Economics, Biogen Idec, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitty Rajagopalan PhD, Director, Global Health Economics, Biogen Idec, Cambridge, MA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Islam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12097938","display_name":"West Virginia University","ror":"https://ror.org/011vxgd24","country_code":"US","type":"education","lineage":["https://openalex.org/I12097938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Islam","raw_affiliation_strings":["Syed Islam PhD, Associate Professor, Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syed Islam PhD, Associate Professor, Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)","institution_ids":["https://openalex.org/I12097938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014246932","display_name":"Jan Kavookjian","orcid":"https://orcid.org/0000-0002-2447-3932","observed_orcids":["https://orcid.org/0000-0002-2447-3932"]},"institutions":[{"id":"https://openalex.org/I82497590","display_name":"Auburn University","ror":"https://ror.org/02v80fc35","country_code":"US","type":"education","lineage":["https://openalex.org/I82497590"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Kavookjian","raw_affiliation_strings":["Jan Kavookjian PhD, Assistant Professor, Pharmacy Care Systems, Harrison School of Pharmacy, Auburn University, Auburn, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan Kavookjian PhD, Assistant Professor, Pharmacy Care Systems, Harrison School of Pharmacy, Auburn University, Auburn, AL","institution_ids":["https://openalex.org/I82497590"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110136704","display_name":"LA Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12097938","display_name":"West Virginia University","ror":"https://ror.org/011vxgd24","country_code":"US","type":"education","lineage":["https://openalex.org/I12097938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.-A. Miller","raw_affiliation_strings":["Lesley-Ann Miller PhD, Assistant Professor, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lesley-Ann Miller PhD, Assistant Professor, School of Pharmacy, West Virginia University, Department of Pharmaceutical Systems and Policy, Robert C Byrd Health Sciences Center (North)","institution_ids":["https://openalex.org/I12097938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.2237,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.8680008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"41","issue":"11","first_page":"1812","last_page":"1818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.11050000041723251,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9919999837875366},{"id":"https://openalex.org/keywords/antipsychotic-medication-adherence","display_name":"antipsychotic adherence","score":0.8119999766349792},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.7760000228881836},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.8809999823570251},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9049999713897705},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8809999823570251},{"id":"https://openalex.org/keywords/medicaid-patients","display_name":"Medicaid patients","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9025286436080933},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8921442627906799},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8327097296714783},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6947071552276611},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6648674011230469},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.6015034914016724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5632278323173523},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5568076968193054},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48216384649276733},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.47995761036872864},{"id":"https://openalex.org/C2778609679","wikidata":"https://www.wikidata.org/wiki/Q4915474","display_name":"Bipolar I disorder","level":5,"score":0.4747857451438904},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4462170898914337},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.4292646646499634},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.42482465505599976},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.41165077686309814},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.30344247817993164},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.20759737491607666},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.10637760162353516},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008484","descriptor_name":"Medicaid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1345/aph.1k205","doi":"https://doi.org/10.1345/aph.1k205","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1k205","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:17925501","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17925501","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2143913225","https://openalex.org/W4235894896","https://openalex.org/W1987228207","https://openalex.org/W1986884907","https://openalex.org/W2510472268","https://openalex.org/W1608528568","https://openalex.org/W2163368395","https://openalex.org/W3098219441","https://openalex.org/W2118780472","https://openalex.org/W4366525624"],"abstract_inverted_index":{"BACKGROUND:":[0],"Medication":[1,96],"nonadherence":[2],"is":[3],"a":[4,27,32,46,86,274],"significant":[5,212],"problem":[6],"among":[7,18],"patients":[8,19,41,181,227,278],"with":[9,20,42,122,241,282],"bipolar":[10,21,43],"disorder.":[11],"OBJECTIVE:":[12],"To":[13],"compare":[14],"adherence":[15,272],"and":[16,76,81,134,163,201,257,273],"persistence":[17,82,189,258],"disorder":[22,44],"initiated":[23,172,182,228,243],"on":[24,67,173,183,229,244],"antipsychotics":[25,167,175,215,231],"in":[26,216],"state":[28],"Medicaid":[29,48],"system":[30],"over":[31,85],"12":[33,87],"month":[34,88],"follow-up":[35,89],"period.":[36,90],"METHODS:":[37],"Claims":[38],"data":[39],"for":[40,126,146,152,158,165,193,196,199,203],"from":[45,109],"de-identified":[47],"database":[49],"were":[50,53,83,144,176,232,259],"examined.":[51],"Patients":[52,171],"classified":[54],"into":[55],"4":[56],"monotherapy":[57],"treatment":[58,113],"groups":[59],"(risperidone,":[60],"olanzapine,":[61,197],"quetiapine,":[62,200],"or":[63,120],"typical":[64,166,174,204,230,266],"antipsychotic)":[65],"based":[66],"the":[68,95,104,110,283],"first":[69],"prescription":[70],"filled":[71],"between":[72,214,261],"January":[73],"1,":[74],"1999,":[75],"December":[77],"31,":[78],"2001.":[79],"Adherence":[80,91,256],"analyzed":[84],"was":[92,101,129,191],"measured":[93],"using":[94,131],"Possession":[97],"Ratio":[98],"(MPR).":[99],"Persistence":[100],"defined":[102],"as":[103],"total":[105],"number":[106],"of":[107,112,218,224,249,277],"days":[108,223,248],"initiation":[111],"to":[114,237],"therapy":[115,219,239,251,280],"modification":[116,220],"(ie,":[117],"discontinuation,":[118],"switching,":[119],"combination":[121],"another":[123],"antipsychotic).":[124],"Adjustment":[125],"confounding":[127],"variables":[128],"undertaken":[130],"ordinary":[132],"least-squares":[133],"Cox":[135,207],"proportional":[136],"hazard":[137],"regression":[138,208],"modeling.":[139],"RESULTS:":[140],"The":[141,265],"mean":[142],"MPRs":[143],"0.68":[145,151],"risperidone":[147,184,245,284],"(n":[148,154,160,168],"=":[149,155,161,169],"231),":[150],"olanzapine":[153],"283),":[156],"0.71":[157],"quetiapine":[159],"106),":[162],"0.46":[164],"205).":[170],"23.6%":[177],"less":[178],"adherent":[179],"than":[180],"(p":[185,252],"<":[186,253],"0.001).":[187,254],"Mean":[188],"(days)":[190],"194.8":[192],"risperidone,":[194],"200.9":[195],"219.8":[198],"179.2":[202],"antipsychotics.":[205],"Extended":[206],"modeling":[209],"indicated":[210],"no":[211],"differences":[213],"hazards":[217],"within":[221],"250":[222,247],"initiation.":[225],"However,":[226],"5.2":[233],"times":[234],"more":[235],"likely":[236],"modify":[238],"compared":[240,281],"those":[242],"after":[246],"antipsychotic":[250,263,267],"CONCLUSIONS:":[255],"similar":[260],"atypical":[262],"groups.":[264],"group,":[268],"however,":[269],"demonstrated":[270],"lower":[271],"greater":[275],"likelihood":[276],"modifying":[279],"cohort.":[285]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}